Paul Cathcart has been a consultant urological surgeon since 2011. Initially appointed at University College London Hospital, Paul moved to Guys and St Thomas NHS Foundation Trust in 2015. He qualified from St George’s Hospital Medical School in 2000 before completing fellowships in uro-oncology and robotic surgery at The Royal Melbourne Hospital and the Peter MacCallum Cancer Centre in Melbourne, Australia.

In addition to having a busy general urological practice, Paul is regarded as an expert both in prostate cancer diagnostics and the surgical management of prostate cancer. Paul performs in excess of 150 robotic prostatectomies each year and has a subspecialist interest in nerve-sparing prostate cancer surgery – where all the nerves around the prostate are preserved to maximise the likelihood of maintaining potency, as well as robotic prostate surgery for men with recurrent prostate cancer. In his NHS practice, Paul has set up a specialist multidisciplinary clinic for men with recurrent prostate cancer that receives referrals from all over the UK and has published his outcomes for men undergoing robotic prostatectomy for recurrent disease.

Paul is Clinical Co-ordinator for the National Prostate Cancer Audit and Chief Investigator for a number of clinical trials including the RAFT study which assesses the effectiveness and safety of salvage robotic prostate cancer surgery after focal therapy.

Paul also enjoys being involved in teaching and training of junior urologists. He is the London training programme director for specialist urology registrar training and is a national selector for the national training programme for urology. Paul is well published in the field of prostate cancer and lectures both nationally and internationally on this subject.

When Paul’s not at work he is usually found out running either training or competing!

Areas of Urological Practice

Prostate cancer diagnostics and management, robotic surgery including salvage robotic radical prostatectomy General urology

References

A Single Educational Seminar Increases Confidence and Decreases Dropout from Active Surveillance by 5 Year After Diagnosis of Prostate Cancer. Kinsella N, Beckmann K, Cahill D, Elhage O, PopertR, Cathcart P, Challacombe B, Brown C, Van Hemelrijck M. Eur Urol Oncol.2019 Jul;2(4):464-470. doi:10.1016/j.euo.2018.09.007. Epub 2018 Oct 11.

Treatment-Related Toxicity Using Prostate-Only Versus Prostate and Pelvic Lymph Node Intensity-Modulated Radiation Therapy: A National Population-Based Study. Parry MG, Sujenthiran A, Cowling TE, NossiterJ, Cathcart P, Clarke NW, Payne H, van der MeulenJ, Aggarwal A.J Clin Oncol. 2019 Jul 20;37(21):1828-1835. doi:10.1200/JCO.18.02237. Epub 2019 Jun 4.

Robot-assisted Radical Prostatectomy After Focal Therapy: Oncological, Functional Outcomes and Predictors of Recurrence. Marconi L, Stonier T, Tourinho-Barbosa R, Moore C, Ahmed HU, Cathelineau X, Emberton M, Sanchez-Salas R, Cathcart P. Eur Urol. 2019 Jul;76(1):27-30. doi: 10.1016/j.eururo.2019.03.007. Epub 2019 Mar 21.

Impact of patient choice and hospital competition on patient outcomes after prostate cancer surgery: A national population-based study. Aggarwal AK, Sujenthiran A, Lewis D, Walker K, Cathcart P, Clarke N, Sullivan R, van der Meulen JH. Cancer. 2019 Jun 1;125(11):1898-1907. doi: 10.1002/cncr.31987. Epub2019 Feb 1.

Impact of cancer service centralisation on the radical treatment of men with high-risk and locally advanced prostate cancer: A national cross-sectional analysis in England. Parry MG, Sujenthiran A, Cowling TE, Nossiter J, Cathcart P, Clarke NW, Payne H, Aggarwal A, van der Meulen J. Int J Cancer. 2019 Jul 1;145(1):40-48. doi: 10.1002/ijc.32068. Epub 2019 Jan 17.

Initial outcomes of local anaesthetic freehand transperineal biopsies in the outpatient setting. Kum F, ElhageO, Maliyil J, Wong K, Faure Walker N, Kulkarni M, Namdarian B, Challacombe B, Cathcart P, Popert R. BJU Int. 2018 Nov 15. doi: 10.1111/bju.14620. [Epub ahead of print]

Treatment-related toxicity in men who received Intensity-modulated versus 3D-conformal radiotherapy after radical prostatectomy: A national population-based study. Sujenthiran A, Nossiter J, Parry M, Charman SC, Cathcart PJ, van der Meulen J, Clarke NW, Payne H, Aggarwal A.Radiother Oncol. 2018 Aug;128(2):357-363. doi: 10.1016/j.radonc.2018.04.032. Epub 2018 May 14.

Robot-assisted radical prostatectomy vs laparoscopic and open retropubic radical prostatectomy: functional outcomes 18 months after diagnosis from a national cohort study in England. Nossiter J, Sujenthiran A, Charman SC, Cathcart PJ, Aggarwal A, Payne H, Clarke NW, van der Meulen J. Br J Cancer. 2018 Feb 20;118(4):489-494. doi: 10.1038/bjc.2017.454. Epub 2018 Jan 18.

A comparison of time taken to return to baseline erectile function following focal and whole gland ablative therapies for localized prostate cancer: A systematic review. Faure Walker NA, Norris JM, Shah TT, Yap T, Cathcart P, Moore CM, Ahmed HU, Emberton M, Minhas S. Urol Oncol. 2018 Feb;36(2):67-76. doi: 10.1016/j.urolonc.2017.12.002. Epub 2017 Dec 23. Review.

King’s Health Partners’ Prostate Cancer Biobank (KHP PCaBB).Saifuddin SR, Devlies W, Santaolalla A, Cahill F, George G, Enting D, Rudman S, Cathcart P, Challacombe B, Dasgupta P, Galustian C, Chandra A, Chowdhury S, Gillett C, Van Hemelrijck M. BMC Cancer. 2017 Nov 22;17(1):784. doi: 10.1186/s12885-017-3773-8.

National cohort study comparing severe medium-term urinary complications after robot-assisted vs laparoscopic vs retropubic open radical prostatectomy. Sujenthiran A, Nossiter J, Parry M, Charman SC, Aggarwal A, Payne H, Dasgupta P, Clarke NW, van der Meulen J, Cathcart P. BJU Int. 2018 Mar;121(3):445-452. doi: 10.1111/bju.14054. Epub 2017 Nov 15..

National Population-Based Study Comparing Treatment-Related Toxicity in Men Who Received Intensity Modulated Versus 3-Dimensional Conformal Radical Radiation Therapy for Prostate Cancer.Sujenthiran A, Nossiter J, Charman SC, Parry M, Dasgupta P, van der Meulen J, Cathcart PJ, Clarke NW, Payne H, Aggarwal A. Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1253-1260. doi: 10.1016/j.ijrobp.2017.07.040. Epub 2017 Sep 1.

Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters.Linch M, Goh G, Hiley C, Shanmugabavan Y, McGranahan N, Rowan A, Wong YNS, King H, Furness A, Freeman A, Linares J, Akarca A, Herrero J, Rosenthal R, Harder N, Schmidt G, Wilson GA, Birkbak NJ, Mitter R, Dentro S, Cathcart P, Arya M, Johnston E, Scott R, Hung M, Emberton M, Attard G, Szallasi Z, Punwani S, Quezada SA, Marafioti T, Gerlinger M, Ahmed HU, Swanton C. Ann Oncol. 2017 Oct 1;28(10):2472-2480. doi: 10.1093/annonc/mdx355.

One Strategy Does Not Fit All: The Era of Personalised Medicine for the Treatment of Male Lower Urinary Tract Symptoms Is upon Us. Tregunna RL, Cathcart P, Bultitude MF. Eur Urol. 2017 Dec;72(6):998-999. doi: 10.1016/j.eururo.2017.07.042. Epub 2017 Aug 12. No abstract available.

Chilli-too hot to handle? Craddock C, Cathcart P, Stebbing J. Lancet Oncol. 2017 Aug;18(8):1005. doi: 10.1016/S1470-2045(17)30522-3. Epub 2017 Jul 26. No abstract available.

Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer. Crawley D, Chandra A, Loda M, Gillett C, Cathcart P, Challacombe B, Cook G, Cahill D, Santa Olalla A, Cahill F, George G, Rudman S, Van Hemelrijck M.BMC Cancer. 2017 Jul 21;17(1):494. doi: 10.1186/s12885-017-3458-3.

Quantifying severe urinary complications after radical prostatectomy: the development and validation of a surgical performance indicator using hospital administrative data.Sujenthiran A, Charman SC, Parry M, Nossiter J, Aggarwal A, Dasgupta P, Payne H, Clarke NW, Cathcart P, van der Meulen J. BJU Int. 2017 Aug;120(2):219-225. doi: 10.1111/bju.13770.Epub 2017 Feb 8.

18F-FECH PET/CT to Assess Clinically Significant Disease in Prostate Cancer: Correlation With Maximum and Total Cancer Core Length Obtained via MRI-Guided Template Mapping Biopsies. Haroon A, Ahmed HU, Cathcart P, Almuhaideb A, Kayani I, Dickson J, Kirkham A, Freeman A, Emberton M, Bomanji J. AJR Am J Roentgenol. 2016 Dec;207(6):1297-1306. Epub 2016 Sep 9.